Atria Investments »

Syndax Pharmaceuticals shares owned by Atria Investments

Quarter-by-quarter ownership of Syndax Pharmaceuticals (SNDX) shares owned by Atria Investments from 13F filings

Historical chart of Atria Investments investment in Syndax Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Syndax Pharmaceuticals held by Atria Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Syndax Pharmaceuticals by Atria Investments

Quarter filed Position value Share count Share price at filing
2024-09-30 $364k 19k 19.25

More positions owned by Atria Investments

Microsoft Corporation (MSFT)
Ishares Tr Core S&p500 Etf (IVV)
Unified Ser Tr Oneascent Core P (OACP)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Apple (AAPL)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Unified Ser Tr Oneascent Intl (OAIM)
Vanguard Index Fds Value Etf (VTV)
Vanguard Index Fds Growth Etf (VUG)
Meta Platforms Cl A (META)
Ishares Tr Core Total Usd (IUSB)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Unified Ser Tr Oneascent Large (OALC)

View all positions for Atria Investments

Top funds holding Syndax Pharmaceuticals

BlackRock
Kynam Capital Management
Wellington Management Company
Vanguard Group
Eversept Partners
venBio Select Advisor
State Street Corporation
Point72 Asset Management
Avidity Partners Management
Assenagon Asset Management
Geode Capital Management
Stempoint Capital
OrbiMed Advisors
Woodline Partners
Franklin Resources

View all funds holding Syndax Pharmaceuticals